Okenite 100 Tablet contains Fluvoxamine 100 mg, a selective serotonin reuptake inhibitor (SSRI) primarily indicated for the treatment of obsessive-compulsive disorder (OCD) and major depressive disorder (MDD). By inhibiting the reuptake of serotonin in the central nervous system, Fluvoxamine increases serotonin availability, thereby enhancing mood and reducing anxiety symptoms. Okenite 100 is prescribed to alleviate symptoms such as persistent intrusive thoughts, compulsive behaviors, and depressive episodes. The medication is typically administered once daily, with dosage adjustments based on clinical response and tolerability. Common side effects may include nausea, headache, insomnia, dry mouth, and dizziness; these are generally transient and resolve with continued treatment. Patients should be monitored for signs of serotonin syndrome, especially when combined with other serotonergic agents. Caution is advised in individuals with a history of bipolar disorder, seizures, or hepatic impairment. Okenite 100 should not be abruptly discontinued to avoid withdrawal symptoms. It is contraindicated in patients with hypersensitivity to Fluvoxamine or any component of the formulation. Prior to initiation, a thorough medical history and medication review are essential to minimize drug interactions and adverse effects. Use during pregnancy and lactation should be under strict medical supervision.